Replies to post #376242 on Elite Pharmaceuticals Inc (ELTP)

[jammy32]

Maybe lack of trust in the CEO

Gets paid 500,000 per year in shares. He benefits from a low stock price

Paid a million per year plus monthly stipend of 1,500 for a car and 5,000 for a house. Why. He’s the CEO of a 45 person operation that does 32 million in revenue. Nice work

Will unwind MIKHA. Nope, will make a deal using them instead.

Dollalland - never even close

Talking about Nasdaq since 2016. Said it would happen in 2017. Nope

FDA cannot stop us. They did. Have some apple sauce

CEO - we are worth more. Guess we’re not.

Owns in excess of at least 300M shares while increasing share count to over a billion - with a f ing B

Nasrat needs to step down and we need a new CEO.

Just my opinion.

[CD_98]

Atta boy JJ. The truth shall set you free!

[jour_trader]

Simple answer. A company can be CFP, but investors are questioning the ability for the company to produce meaningful future value to shareholders. Also, the company also has a billion shares outstanding and has diluted heavily. There may also be concerns regarding the transition away from Lannett (e.g., need to raise cash to survive if transition doesn’t go as well as expected).

Building confidence is as simple as doing what management says they will do. If they do, stock rises as confidence is built in investment community. Don’t do it and blindside shareholders will decimate any stock, regardless if profitable.

How many times have Elite’s shareholders been surprised with news to the downside?